Protein Identified As Target for Spinal Cord Repair
Researchers found that increasing a specific protein may help reduce inflammation and improve recovery after injury.
Updated on Sept. 21, 2026 in Stroke
Scientists have identified the protein METTL14 as a key regulator of brain and spinal cord recovery. This finding suggests a potential pathway for improving functional healing in patients dealing with spinal cord injuries.
Why it matters
Persistent neuroinflammation often hinders natural tissue repair after a spinal cord injury. By regulating this biological response, researchers hope to open new avenues for future therapeutic interventions.
This preclinical study utilized transcriptomic analysis to identify ATG13 as a target of METTL14 in microglial cells. Researchers observed that manipulating METTL14 levels altered both autophagic activity and inflammatory cytokine production.
The players
METTL14
A protein regulator identified as a key factor in microglial autophagy and neuroinflammation.
ATG13
An autophagy-related gene and primary target for METTL14-mediated regulation.
The details
METTL14 functions as a regulatory protein that modulates the m6A modification of ATG13, a gene essential for autophagy. By enhancing autophagic activity in microglia—the immune cells of the central nervous system—METTL14 helps suppress the inflammatory response that typically prevents tissue recovery. In experimental models, viral overexpression of METTL14 successfully increased this autophagic activity, leading to improved neurological outcomes.
Timeline
Two weeks post-injury: METTL14 and global m6A levels were observed to increase in the spinal cord.
Health Landscape
This research contributes to the emerging field of epitranscriptomic regulation, which seeks to modify genetic expression without altering the underlying DNA. It sits within a broader scientific effort to overcome the limited regenerative capacity of the central nervous system.
This is a laboratory-based discovery, not a clinical treatment, and it does not currently change existing medical care. Any questions regarding new research into spinal cord injury recovery are best discussed with a neurologist or specialist.
The takeaway
The discovery of METTL14 as a regulator of inflammation suggests that the body's internal management of gene expression may one day be a target for tissue repair. Patients and families tracking recovery research should focus on the growing role of epitranscriptomics in future regenerative therapies.
Further reading
Learn more about the latest innovations in neuro-recovery research at our Stroke section.
More information
Review the full findings in the peer-reviewed research article published in Communications Biology.
Source note: This article includes information reported by Nature.
